Dipexium Pharmaceuticals, Inc. (NASDAQ:PLXP) insider Michael J. Valentino purchased 29,091 shares of the company’s stock in a transaction dated Wednesday, June 14th. The shares were acquired at an average cost of $6.88 per share, with a total value of $200,146.08. Following the purchase, the insider now directly owns 122,386 shares of the company’s stock, valued at approximately $842,015.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Dipexium Pharmaceuticals, Inc. (PLXP) traded down 9.16% during trading on Friday, hitting $5.95. 48,344 shares of the stock traded hands. The company has a 50-day moving average price of $6.45 and a 200-day moving average price of $9.81. The stock’s market cap is $26.08 million. Dipexium Pharmaceuticals, Inc. has a 12 month low of $5.60 and a 12 month high of $142.01.
Dipexium Pharmaceuticals (NASDAQ:PLXP) last announced its quarterly earnings data on Monday, April 17th. The biotechnology company reported ($0.14) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.12) by $0.02.
ILLEGAL ACTIVITY WARNING: “Dipexium Pharmaceuticals, Inc. (PLXP) Insider Purchases $200,146.08 in Stock” was originally reported by sleekmoney and is the sole property of of sleekmoney. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://sleekmoney.com/dipexium-pharmaceuticals-inc-plxp-insider-purchases-200146-08-in-stock/1915950.html.
Dipexium Pharmaceuticals Company Profile
PLx Pharma Inc, formerly Dipexium Pharmaceuticals, Inc, is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325 mg, PL1100/PL1200 Ibuprofen.
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/dipexium-pharmaceuticals-inc-plxp-insider-purchases-200146-08-in-stock/1915950.html
Receive News & Ratings for Dipexium Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dipexium Pharmaceuticals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.